Hitachi Ventures and Optum Ventures contributed to a $110m round for precision immunology technology developer Scipher, already backed by Echo Health Ventures.

US-based precision immunology therapy developer Scipher Medicine closed a $110m funding round today featuring Hitachi Ventures and Optum Ventures, on behalf of electronics conglomerate Hitachi and healthcare services provider Optum respectively.

Cowen Healthcare Investments led the round, which was filled out by Neuberger Berman, Laurion Capital, Monashee Investment Management, Northpond Ventures, aMoon, Khosla Ventures, Echo Innovation Alliance and Alumni Ventures.

Founded in 2014, Scipher has developed a system that uncovers a patient’s unique molecular disease signature and identifies…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Thierry Heles

Thierry Heles is the editor of Global University Venturing, host of the Beyond the Breakthrough interview podcast and responsible for the monthly GUV Gazette (sign up here for free).
email Linked in